2023
DOI: 10.1016/j.molstruc.2022.133932
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and in vitro anticancer activity of 4H-pyrano[2,3-d]pyrimidine−1H-1,2,3-triazole hybrid compounds bearing D-glucose moiety with dual EGFR/HER2 inhibitory activity and induced fit docking study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 37 publications
0
8
0
Order By: Relevance
“…Yields of substituted ethyl 4 H -pyran-3-carboxylates were 63–75% (Table S2 in the ESI†). 33 Reaction of these ethyl esters with acetic anhydride in the presence of trifluoroacetic acid (TFA) as catalyst under reflux at 100 °C for 15 min led to the production of 4 H -pyrano[2,3- d ]pyrimidines 7a–g and 8a–g , respectively (Scheme 2). 34 These compounds were formed with yields of 69–78% (Table S3 in the ESI†).…”
Section: Resultsmentioning
confidence: 99%
“…Yields of substituted ethyl 4 H -pyran-3-carboxylates were 63–75% (Table S2 in the ESI†). 33 Reaction of these ethyl esters with acetic anhydride in the presence of trifluoroacetic acid (TFA) as catalyst under reflux at 100 °C for 15 min led to the production of 4 H -pyrano[2,3- d ]pyrimidines 7a–g and 8a–g , respectively (Scheme 2). 34 These compounds were formed with yields of 69–78% (Table S3 in the ESI†).…”
Section: Resultsmentioning
confidence: 99%
“…Thanh and co-workers synthesized a series of 36 derivatives of 4H-pyrano[2,3-d]pyrimidine 515a-zj by click cycloaddition reaction of polysubstituted 4H-pyrano[2,3-d]pyrimidines 514azj 167 containing propargyl group on nitrogen atom with peracetylated D-glucopyaranosyl azide 7 by using ultrasound, CuNPs@Montmorillonite as a catalyst and DIPEA in the presence of t BuOH/H2O at 25°C (Scheme 51). 168 Scheme 51 Synthesis of compounds 515a-zj All the synthesized compounds 515a-zj were tested against five typical human cancer cell lines, including breast adenocarcinoma cells MCF-7, hepatocellular carcinoma cells HepG2 and cervical cancer cells HeLa by using three reference drugs-Doxorubicin (DOX), Lapatinib, and Erlotinib then it was found that Some compounds, such as 515v, 515x, 515z, 515zc, 515zf, and 515zg against MCF-7, 515s, 515t, 515w, 515zh and 515zi against HepG2, and 515h, 515j, 515zf, and 515zh against HeLa cancer cell lines, demonstrated excellent activity against tested cancer cell lines with IC50 < 4 μM. In comparison to lapatinib, compounds 8v, 8z, 8zc, and 8zf significantly inhibited the activity of EGFR and HER2 tyrosine kinases.…”
Section: Template For Synopen Thiemementioning
confidence: 99%
“…It has been reported in previous studies that the active site of the targeted receptor was mainly composed of residues Phe699, Gly700, Lys721, Met769, Arg817, Thr830, and Asp831. 35,36 The hydrophobic pockets formed with compound 21g are revealed in Figure 3, involving residues Leu694, Val702, Alaa719, Leu768, and Leu820. The interaction is further strengthened through two conventional hydrogen bonds with Lys721 and Met769.…”
Section: Docking Studiesmentioning
confidence: 99%